Beam Therapeutics Inc (BEAM) Stock Price, Quote & News

Company Profile

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease; BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. It also intends to develop BEAM-103, an anti-CD117 monoclonal antibody, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 857 327 8775

Website: beamtx.com

Address:

238 Main Street, Cambridge, United States

_ReversalTrackers Feb. 17 at 4:10 PM

$BB $TTMI $BEAM ]

0 · Reply

Lonnies Feb. 17 at 1:31 PM

$BEAM pre +0.43% into 50DMA 28 I’m short, rejection setup

0 · Reply

someguytrades Feb. 13 at 10:36 PM

$NTLA $30, $BEAM $150 $CRSP $100 $PRME $1.50

2 · Reply

Bullishshane Feb. 13 at 5:24 PM

$BEAM I’m quite positive that this will hit $30 by the 23rd of feb, Looks rather strong hopefully it keeps up the momentum 💪🏻

0 · Reply

Estimize Feb. 11 at 11:00 AM

Wall St is expecting -1.16 EPS for $BEAM Q1 [Reporting 05/12 BMO] http://www.estimize.com/intro/beam?chart=historical&metric_name=eps&utm_c

0 · Reply

mankind1 Feb. 10 at 7:40 PM

$BEAM this is still a with while stock.

0 · Reply

EncryptedFloat Feb. 7 at 12:36 PM

$BEAM needs news

0 · Reply

LinoeuSoul Feb. 6 at 9:39 PM

$BEAM This is my portfolio. Yesterday it was all red. I didn’t sell — I rebalanced and added. Short-term price action is noise; long-term compounding is the strategy. Process over emotion. Horizon over headlines. 2030.

0 · Reply

CarbonSpirit Feb. 5 at 4:00 PM

$BEAM So what we are seeing currently is a bit of a correction, but when you look at the 1yr NASDAQ chart, it has some way to go…. Downside is that if shifts the algorithms to either cash accumulate or go to lower risk stocks. But today we are just getting pulled with the market, downwards sadly. Maybe the weaker jobs data will increase the argument for a rate cut, this is usually good news for XBI

0 · Reply